Abstract
Systems biology promises to describe and model complete biological systems quantitatively. Recently, in many areas of biological research, focus has shifted from detailed characterization of an individual gene or gene function in terms of its effect on a cellular process (the reductionist approach) to understanding the behavior of networks of genes or gene products from a genome-wide perspective (the systems biology approach). Here we review how analyses that allowed genome-wide investigations (by mining and integrating data from various “omics”) have contributed to our understanding of biological processes from genes to networks. We will discuss these advances in terms of quantitative leaps in which the scope of a known process was only revealed by genome studies (e.g., fraction of genes with alternative transcription start sites, splicing isoforms, or protein isoforms) and qualitative leaps in which completely new phenomena have been revealed (e.g., dark matter in the genome, functional pseudogenes, scale-free protein networks, fluidity of microbial genomes, and the diversity of the microbiome). We will discuss what the future holds for systems biology in terms of unrealized leaps that may provide new surprises from the viewpoints of academic and biomedical research.
Current Proteomics
Title: Systems Biology: Understanding Function from Genes to Networks
Volume: 6 Issue: 2
Author(s): Ravinder Singh and Rob Knight
Affiliation:
Abstract: Systems biology promises to describe and model complete biological systems quantitatively. Recently, in many areas of biological research, focus has shifted from detailed characterization of an individual gene or gene function in terms of its effect on a cellular process (the reductionist approach) to understanding the behavior of networks of genes or gene products from a genome-wide perspective (the systems biology approach). Here we review how analyses that allowed genome-wide investigations (by mining and integrating data from various “omics”) have contributed to our understanding of biological processes from genes to networks. We will discuss these advances in terms of quantitative leaps in which the scope of a known process was only revealed by genome studies (e.g., fraction of genes with alternative transcription start sites, splicing isoforms, or protein isoforms) and qualitative leaps in which completely new phenomena have been revealed (e.g., dark matter in the genome, functional pseudogenes, scale-free protein networks, fluidity of microbial genomes, and the diversity of the microbiome). We will discuss what the future holds for systems biology in terms of unrealized leaps that may provide new surprises from the viewpoints of academic and biomedical research.
Export Options
About this article
Cite this article as:
Singh Ravinder and Knight Rob, Systems Biology: Understanding Function from Genes to Networks, Current Proteomics 2009; 6 (2) . https://dx.doi.org/10.2174/157016409788680974
DOI https://dx.doi.org/10.2174/157016409788680974 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Integral Therapeutic Potential of Bone Marrow Mesenchymal Stem Cells
Current Drug Targets Anticancer Potential of Ginger: Mechanistic and Pharmaceutical Aspects
Current Pharmaceutical Design Anal Cancer: Focus on HIV-Positive Patients in the HAART Era
Current HIV Research Transporters at CNS Barrier Sites: Obstacles or Opportunities for Drug Delivery?
Current Pharmaceutical Design Established Treatments of Psoriasis
Current Drug Targets - Inflammation & Allergy The Frequency of Thrombotic Events Among Adults Given Antifibrinolytic Drugs for Spontaneous Bleeding: Systematic Review and Meta-Analysis of Observational Studies and Randomized Trials
Current Drug Safety Vascular Endothelial Growth Factor Receptors [VEGFR] as Target in Breast Cancer Treatment: Current Status in Preclinical and Clinical Studies and Future Directions
Current Topics in Medicinal Chemistry L-Sulforaphane Confers Protection Against Oxidative Stress in an In Vitro Model of Age-Related Macular Degeneration
Current Molecular Pharmacology Optimal Saturated Neuropilin-1 Expression in Normal Tissue Maximizes Tumor Exposure to Anti-Neuropilin-1 Monoclonal Antibody
Anti-Cancer Agents in Medicinal Chemistry Inflammatory Mediators Hold the Key to Dendritic Cell Suppression and Tumor Progression
Current Medicinal Chemistry Role of Genetics and Epigenetics in Mucosal, Uveal, and Cutaneous Melanomagenesis
Anti-Cancer Agents in Medicinal Chemistry Pharmacognostical Overview of “Gunma Kuligai” – a Traditional Siddha Preparation for Treating Acid Peptic Disease (APD)
Current Traditional Medicine Herpes Simplex Encephalitis: From Virus to Therapy
Infectious Disorders - Drug Targets Mining the Genome for Susceptibility to Complex Neurological Disorders
Current Molecular Medicine Genetic Dissection of Complex Traits In Silico: Approaches, Problems and Solutions
Current Bioinformatics Melatonin Receptor Agonists: SAR and Applications to the Treatment of Sleep-Wake Disorders
Current Topics in Medicinal Chemistry Emergency Services: A Birds Eye Perspective on the Many Different Functions of Stress Proteins
Current Protein & Peptide Science Flavonoids as Sirtuin Modulators
Current Topics in Medicinal Chemistry How Do Periodontal Infections Affect the Onset and Progression of Alzheimer’s Disease?
CNS & Neurological Disorders - Drug Targets Soluble Forms of RAGE in Human Diseases: Clinical and Therapeutical Implications
Current Medicinal Chemistry